ADMA Biologics Inc (ADMA)
Fixed asset turnover
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Revenue | US$ in thousands | 426,454 | 258,215 | 154,080 | 80,943 | 42,220 |
| Property, plant and equipment | US$ in thousands | 54,707 | 53,835 | 58,261 | 50,935 | 41,593 |
| Fixed asset turnover | 7.80 | 4.80 | 2.64 | 1.59 | 1.02 |
December 31, 2024 calculation
Fixed asset turnover = Revenue ÷ Property, plant and equipment
= $426,454K ÷ $54,707K
= 7.80
The fixed asset turnover ratio of ADMA Biologics Inc has been steadily increasing over the past five years. In December 31, 2020, the ratio stood at 1.02, indicating that the company generated $1.02 in sales for every dollar invested in fixed assets.
By December 31, 2021, the ratio had increased to 1.59, showing an improvement in efficiency in utilizing fixed assets to generate revenue. This trend continued in subsequent years with the ratio reaching 2.64 by December 31, 2022, 4.80 by December 31, 2023, and a significant jump to 7.80 by December 31, 2024.
The rising trend in fixed asset turnover indicates that ADMA Biologics Inc has been effectively utilizing its fixed assets to drive sales growth and productivity. This could be a positive indicator of operational efficiency and effective management of asset utilization within the company.
Peer comparison
Dec 31, 2024